Saturday, January 23, 12noon, this on-line event requires advance registration

This webinar will feature a discussion of the many ways that gene therapies can be used to address retinal degenerative diseases as well as the latest updates on gene therapy research and clinical trials.

Our panelists will provide insights into emerging gene therapies and the latest technologies that are in the pipeline.

• John Flannery, PhD, UC Berkeley, scientific co-founder of Vedere

• Shannon Boye, PhD, University of Florida, scientific co-founder of Atsena

• Pete Adamson, Vice President of Janssen Ophthalmology Disease Stronghold Area

These webinars are presented without charge and are brought to you by The Chatlos Foundation Public Health Education Program of the Foundation Fighting Blindness.

RSVP for this event by using this link.

Hosted by Foundation Fighting Blindness.